Abstract:Jingxia Wang, 1, 2, &ast Qiangqiang Xiang, 1, 2, &ast Silan Gu, 1, &ast Yudan Gu, 3 Mingfei Yao, 1 Weixin Huang, 4, 5 Wang Gao, 4 Ling-Ling Tang 1, 2 1 State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, People's Republic of China; 2 Shulan (Hangzhou) Hospital Affiliated to Zhejiang Shuren University, Shulan International Medical College, Hangzhou, People's Republic of China; 3 Zhejiang Chinese Medical University, Hangzhou, People's Republic of China; 4 Jinan Microecological Biomedicine Shandong Laboratory, Jinan, People's Republic of China; 5 Shaoxing Tongchuang Biotechnology Co., Ltd, Shaoxing, People's Republic of China &astThese authors contributed equally to this work Correspondence: Ling-Ling Tang, Shulan (Hangzhou) Hospital Affiliated to Zhejiang Shuren University, Shulan International Medical College, Hangzhou, People's Republic of China, Email Background: Antibiotics are the first line of treatment for infectious diseases. However, their overuse can increase the spread of drug-resistant bacteria. The present study analyzed the impact of different types of antibiotics on the gut microbiome and cytokines level of mice. Methods: A total of five groups of 8-week-old male BALB/c mice (n = 35) were treated with piperacillin-tazobactam (TZP), ceftriaxone (CRO), tigecycline (TGC), levofloxacin (LEV) or normal saline (Ctrl), respectively, for up to 4 weeks. Fecal samples were analyzed by bacterial 16S rRNA gene sequencing for bacterial identification. Blood samples were used for the determination of 23 serum cytokines using multiplex immunoassay. Results: Exposure to antibiotics was shown to affect the normal weight gain of mice. Significant changes in gut composition caused by TZP, CRO and TGC treatment included the decreased abundance of Bacteroidetes (p < 0.01), Muribaculaceae (p < 0.01) and Lachnospiraceae (p < 0.01), and the increased abundance of Proteobacteria (p < 0.05), Enterobacteriaceae (including Klebsiella and Enterobacter ) (p < 0.01) and Enterococcaceae (including Enterococcus ) (p < 0.01). After 4-week treatment, the TZP, CRO and LEV groups had significantly lower concentrations of several serum cytokines. Correlation analysis of the top 30 bacterial genera and cytokines showed that Enterococcus and Klebsiella were strongly positively correlated with tumor necrosis factor-α (TNF-α), interleukins (IL) IL-12p70 and IL-1β. Desulfovibrio, Candidatus Saccharimonas, norank_f__norank_o__Clostridia_UCG-014, Lactobacillus , and Roseburi a were strongly negatively correlated with these cytokines. Conclusion: This study demonstrates the effects of various antibiotics on the intestinal microflora and immune status of mice. Compared with TZP, CRO and TGC, LEV had minimal impact on the gut microbiota. In addition to TGC, long-term TZP, CRO and LEV intervention can lead to a decrease in serum cytokine levels, which may depend on the intestinal microflora, antibiotic used and the duration of treatment. Keywords: gut microbiota, piperacillin-tazobactam, ceftriaxone, tigecycline, levofloxacin, cytokine, immunity Since the discovery of penicillin by Alexander Fleming in 1928, antibiotics have been widely used to save millions of lives. 1 However, the overuse and misuse of antibiotics have become a worldwide problem. There is increasing concern that antibiotic exposure may result in short- and/or long-term non-beneficial consequences, including an increased risk of necrotizing enterocolitis, bronchial allergy and asthma, obesity and autoimmune diseases. 2–6 In recent years, disruption of the intestinal microbiota by antibiotics has received increasing attention. Some studies have demonstrated a direct link between antibiotic use and alterations in the intestinal microbiota. 7–10 Moreover, it was found that antibiotic inducing changes in the gut microbiota may affect normal immune function or immune status by disrupting metabolic homeostasis. 11–13 Among various antibiotics, the side effect of broad-spectrum antibiotics is easy to be depreciated as they are widely used in human and animal disease prevention and treatment. However, long-term high-dose application of broad-spectrum antibi -Abstract Truncated-

Vancomycin and ceftriaxone can damage intestinal microbiota and affect the development of the intestinal tract and immune system to different degrees in neonatal mice.

Loading ceftriaxone, vancomycin, and Bifidobacteria bifidum TMC3115 to neonatal mice could differently and consequently affect intestinal microbiota and immunity in adulthood

Effect Of The Short-Term Use Of Fluoroquinolone And Beta-Lactam Antibiotics On Mouse Gut Microbiota

Effect of ceftriaxone on the intestinal epithelium and microbiota in neonatal mice

Vancomycin-induced gut microbial dysbiosis alters enteric neuron-macrophage interactions during a critical period of postnatal development

Antibiotic Exposure Prevents Acquisition of Beneficial Metabolic Functions in the Preterm Infant Gut Microbiome

Antibiotic-Induced Disruption of Gut Microbiota Alters Local Metabolomes and Immune Responses

Peripartum Antibiotics Promote Gut Dysbiosis, Loss of Immune Tolerance, and Inflammatory Bowel Disease in Genetically Prone Offspring

Long-term use of ceftriaxone sodium induced changes in gut microbiota and immune system

Neonatal antibiotic treatment alters gastrointestinal tract developmental gene expression and intestinal barrier transcriptome

Antibiotic Treatment Affects Intestinal Permeability and Gut Microbial Composition in Wistar Rats Dependent on Antibiotic Class

Short-term use of ceftriaxone sodium leads to intestinal barrier disruption and ultrastructural changes of kidney in SD rats

Short-term exposure to antibiotics begets long-term disturbance in gut microbial metabolism and molecular ecological networks

An Antibiotic-Impacted Microbiota Compromises the Development of Colonic Regulatory T Cells and Predisposes to Dysregulated Immune Responses

Short- and Long-Term Effects of Different Antibiotics on the Gut Microbiota and Cytokines Level in Mice

Antibiotic-associated dysbiosis affects the ability of the gut microbiota to control intestinal inflammation upon fecal microbiota transplantation in experimental colitis models

Antepartum Antibiotic Treatment Increases Offspring Susceptibility to Experimental Colitis: A Role of the Gut Microbiota

Modulation of Lactobacillus Rhamnosus GG on the Gut Microbiota and Metabolism in Mice with Clostridioides Difficile Infection

Antibiotic-Induced Dysbiosis of the Gut Microbiota Impairs Gene Expression in Gut-Liver Axis of Mice

Antibiotic perturbation of the preterm infant gut microbiome and resistome

Dysbiosis of Intestinal Microbiota in Early Life Aggravates High-Fat Diet Induced Dysmetabolism in Adult Mice